Business Context and Reporting Period
Company: Alterity Therapeutics Limited (a development stage enterprise)
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Date: January 15, 2026
Headquarters: Melbourne, Victoria, Australia
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. As a development stage enterprise, the document does not contain a financial statement or performance metrics for the period.
Material Changes
No material changes to financial position or operations are detailed in this specific filing. The document serves primarily as a notification regarding unquoted securities.
Guidance, Outlook, and Risks
Management Commentary: None provided in this filing.
Risks and Contingencies: The filing references an exhibit (99.1) titled "Notification regarding unquoted securities - ATH," indicating a corporate action or disclosure related to securities not currently quoted on an exchange. No specific risk factors or outlook guidance are included in the text.
Investor Verification Checklist
- Review Exhibit 99.1 for details on the "unquoted securities" notification.
- Verify the status of the referenced Registration Statements (Form S-8 and Form F-3) for potential capital raising activities.
- Confirm the company's current cash runway and burn rate, as this filing does not disclose liquidity metrics.
- Check for subsequent filings that may contain the full text of the unquoted securities notification.